MEDP vs NOTV

Medpace Holdings, Inc. vs Inotiv, Inc. — Valuation Comparison 2026

By CirclFi Research Team · Updated 2026-06-03 · Data from SEC EDGAR, FRED & GDELT

Quick Summary — MEDP scores higher on quality with 10.0/10 vs NOTV's 5.5/10. MEDP trades at $445.59 while NOTV trades at $0.26. Both analyzed daily using SEC EDGAR data across 13 institutional models.

MEDP

Diagnostics & Research
Medpace Holdings, Inc.
Quality
10.0
out of 10
Value Trap
6
SAFE
Price
$445.59
Last close
Models
11/13
Active
VS

NOTV

Diagnostics & Research
Inotiv, Inc.
Quality
5.5
out of 10
Value Trap
29
LOW
Price
$0.26
Last close
Models
1/13
Active
MEDP
Quality Score 10.0/10 — top tier
Limited to 2/13 visible models
NOTV
ML-RIV sees +322.3% upside
Limited to 1/13 visible models

MEDP vs NOTV — Fair Value Comparison

MEDP
$0$175$351$526 Price$445.59 Bayesian …$389.44 (-12.6%) Earnings …$195.85 (-56.0%)
NOTV
$0$0$1$1 Price$0.26 ML-RIV$1.10 (+322.3%)
Market Price Model 1 Model 2

Model-by-Model Comparison

ModelType MEDP Fair ValueMEDP Upside NOTV Fair ValueNOTV Upside
Bayesian DCF Intrinsic $389.44 -12.6%
Earnings Power Value Intrinsic $195.85 -56.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $132.77 -70.2% $1.10 +322.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%

MEDP vs NOTV — Which Stock Is More Undervalued in 2026?

MEDP scores higher with a 10.0/10 quality rating vs NOTV's 5.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do MEDP and NOTV Valuations Compare?

MEDP currently trades at $445.59 while NOTV trades at $0.26. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily for both companies.

Quality of Company: MEDP vs NOTV

MEDP earns a Quality of Company score of 10.0/10 compared to NOTV's 5.5/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: MEDP vs NOTV

MEDP carries a SAFE value trap risk (6/100) while NOTV shows LOW risk (29/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Diagnostics & Research

Both MEDP and NOTV operate in Diagnostics & Research, which has 48 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare MEDP vs NOTV differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo  ·  FactSet: ~$1,000/mo  ·  CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

See all Diagnostics & Research stocks →